Health
ALLERGAN AESTHETICS HIGHLIGHTS MEDICAL WEIGHT LOSS (MWL) DATA AND THE CHANGING PROFILE OF PATIENTS
Allergan Aesthetics, an AbbVie company, shares new data illustrating how the rapid adoption of Medical Weight Loss (MWL) treatments is changing patient behavior, aesthetic priorities, and treatment demand, particularly as facial volume loss emerges as a leading concern.
About this update from Abbvie Inc.
[{"type":"text","content":"Data shows a rise in specific treatment demand; a shift in patient consultation and the rising role of facial volume restoration ","length":128,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"67% of patients say MWL treatment changed their goals toward improving appearance, not just weight reductioni.","length":115,"tagName":"p"}]},{"val":[{"type":"text","content":"Nearly half of MWL patients (47%) were reported by HCPs to benefit most from hyaluronic acid injectable fillers when addressing post-weight-loss facial concernsii.","length":168,"tagName":"p"}]},{"val":[{"type":"text","content":"60% of consumers receiving GLP-1 medications obtain them from providers who also offer aesthetic treatments, up from 49% in late 2024iii.","length":142,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":425,"olType":false},{"type":"text","content":"IRVINE, Calif., March 4, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, shares new data illustrating how the rapid adoption of Medical Weight Loss (MWL) treatments is changing patient behavior, aesthetic priorities, and treatment demand, particularly as facial volume loss emerges as a leading concern.","length":321,"tagName":"p"},{"type":"image","alt":"Allergan Aesthetics Highlights Medical Weight Loss (MWL) Data and the Changing Profile of Patients","displaySize":"","headline":null,"caption":"Allergan Aesthetics Highlights Medical Weight Loss (MWL) Data and the Changing Profile of Patients","className":"","disableSlideshowImg":false,"size":{"original":{"width":155,"height":200,"url":"https://media.zenfs.com/en/prnewswire.com/8b020c515b0f3bc675a392fd471a6534"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QziA4F5Drr7jl3SuiToKig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTI3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/8b020c515b0f3bc675a392fd471a6534","width":155,"height":200}},"href":"https://mma.prnewswire.com/media/2925409/ABBVIE_Allergan_Aesthetics_data.pdf?p=original","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Allergan Aesthetics is committed to equipping our customers with data-driven insights, education, and consultation tools to help guide patients safely and effectively through these changes," said Glen Curran, Senior Vice President at Allergan Aesthetics. "We'r...